The Physiological Society and Wiley have signed a new publishing contract for The Journal of Physiology and Experimental Physiology, in a partnership that has grown steadily since it…
The most diverse functions of a cell in the human body – from cell division and differentiation to motility and programmed cell death – are controlled by signalling proteins within the cell. This includes the immune system and the reading of…
Half a million evacuees in Cambodia and Thailand are sheltering in pagodas, schools and other safe havens after fleeing a renewed eruption of fighting in a…
Vortex Liquid Biopsy Solutions has launched a new clinical study with The Doctors Laboratory to assess how its live-cell liquid biopsy technology could change cancer monitoring and treatment.
Diminished ovarian reserve (DOR) is characterized by a reduction in both the quantity and quality of ovarian follicles, most often diagnosed by low anti-Müllerian hormone (AMH) levels and/or a decreased antral follicle count (AFC).
Elon Musk’s space exploration company SpaceX is preparing to list on the stock market next year in a move that could raise more than $25bn (£19bn) and value the business at more than $1tn, according to reports.
SpaceX, which designs, builds and launches rockets, is said to have started discussions with banks about an initial public offering (IPO). It could join the stock market in about June or July, according Reuters, which cited an unnamed source familiar with the matter.
A flotation could rival the market value that the oil company Saudi Aramco achieved during its listing in 2019, which remains the biggest in history. It raised $29bn at the time, at a valuation of $1.7tn.
SpaceX could raise “significantly more than £30bn”, according to a separate report by Bloomberg, which said Musk was targeting an overall valuation of about $1.5tn.
Reuters said SpaceX planned to use the funds from the public listing to fund its space-based datacentres, including buying the chips required to run them.
The company was expected to make about $15bn in revenue in 2025, rising to between $22bn and $24bn in 2026, Bloomberg reported. Most of this is due to come from Starlink, its internet satellite business.
Last week, media reports suggested SpaceX was in talks with investors about a share sale that would value it at $800bn, pitting it against OpenAI to become the most valuable private company in the world.
However, Musk said the reports were inaccurate on Saturday. He wrote: “SpaceX has been cashflow positive for many years and does periodic stock buybacks twice a year to provide liquidity for employees and investors. Valuation increments are a function of progress with Starship and Starlink and securing global direct-to-cell spectrum that greatly increases our addressable market.”
